Hint mode is switched on Switch off

Fulcrum Therapeutics, ordinary share
FULC, US3596161097

Add a stock to WL
Choose all Reset all
Fulcrum Therapeutics, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

  • Issuer
  • Full borrower / issuer name
    Fulcrum Therapeutics Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    FULC
  • Placement
    18.07.2019
  • Lock up period
    180
  • Number of papers
    4,500,000
  • Volume of raised funds
    72 mln USD
  • Placement share
    19.28%
  • Final placement price
    16 USD
  • Price change since placement date
    -100%
  • By capitalization
    373.44 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    FULC
  • Placement
    20.01.2021
  • Lock up period
    180
  • Number of papers
    4,000,000
  • Volume of raised funds
    44 mln USD
  • Placement share
    12.47%
  • Final placement price
    11 USD
  • Price change since placement date
    -67.45%
  • By capitalization
    352.74 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    FULC
  • Placement
    11.12.2025
  • Lock up period
    180
  • Number of papers
    11,851,853
  • Volume of raised funds
    160 mln USD
  • Placement share
    17.97%
  • Final placement price
    13.5 USD
  • Price change since placement date
    -73.48%
  • By capitalization
    890.46 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2026
I q eng
II q eng
2025
I q eng
II q eng
III q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
II q eng
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

05/06/2026 Fulcrum Therapeutics: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers
03/06/2026 Fulcrum Therapeutics (NASDAQ: FULC) Stock Plunges Amid Drug Discontinuation and Downgrade
01/06/2026 Fulcrum Therapeutics: Other Events, Financial Statements And Exhibits
31/05/2026 Fulcrum Therapeutics: Costs Associated With Exit Or Disposal Activities, Other Events
23/04/2026 Fulcrum Therapeutics: Termination Of A Material Definitive Agreement, Results Of Operations And Financial Condition, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.